Top-Rated StocksTop-RatedNYSE:PHR Phreesia (PHR) Stock Price, News & Analysis → Make This $3 Trade the Instant the Opening Bell Rings (From Monument Traders Alliance) (Ad) Free PHR Stock Alerts $22.93 -0.82 (-3.45%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$21.80▼$23.8650-Day Range$22.70▼$28.8752-Week Range$12.05▼$36.13Volume693,167 shsAverage Volume546,906 shsMarket Capitalization$1.28 billionP/E RatioN/ADividend YieldN/APrice Target$32.71 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Phreesia alerts: Email Address Phreesia MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.87 Rating ScoreUpside/Downside42.7% Upside$32.71 Price TargetShort InterestHealthy3.70% of Shares Sold ShortDividend StrengthN/ASustainability-0.60Upright™ Environmental ScoreNews Sentiment0.32Based on 39 Articles This WeekInsider TradingSelling Shares$246,213 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.47) to ($1.31) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.86 out of 5 starsMedical Sector102nd out of 947 stocksHealth Information Services Industry1st out of 3 stocks 4.4 Analyst's Opinion Consensus RatingPhreesia has received a consensus rating of Moderate Buy. The company's average rating score is 2.87, and is based on 13 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $32.71, Phreesia has a forecasted upside of 42.7% from its current price of $22.93.Amount of Analyst CoveragePhreesia has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 5.0 Short Interest Percentage of Shares Shorted3.70% of the outstanding shares of Phreesia have been sold short.Short Interest Ratio / Days to CoverPhreesia has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Phreesia has recently decreased by 10.04%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldPhreesia does not currently pay a dividend.Dividend GrowthPhreesia does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScorePhreesia has received a 60.31% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Patient flow management systems", "Health care management software", and "Personal health record software" products. See details.Environmental SustainabilityThe Environmental Impact score for Phreesia is -0.60. Previous Next 2.4 News and Social Media Coverage News SentimentPhreesia has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 39 news articles for Phreesia this week, compared to 4 articles on an average week.Search InterestOnly 3 people have searched for PHR on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows6 people have added Phreesia to their MarketBeat watchlist in the last 30 days. This is an increase of 20% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Phreesia insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $246,213.00 in company stock.Percentage Held by InsidersOnly 5.80% of the stock of Phreesia is held by insiders.Percentage Held by Institutions94.37% of the stock of Phreesia is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Phreesia are expected to grow in the coming year, from ($1.47) to ($1.31) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Phreesia is -9.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Phreesia is -9.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPhreesia has a P/B Ratio of 4.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyUrgent new message from Porter StansberryI’ve been in the financial markets for close to three decades… Yet, I’ve never seen an opportunity that’s so urgent, so critical, and yet so overlooked than what is unfolding right now. You see, in one corner of the markets a financial anomaly has emerged that promises to be the single most important story of 2024.Click here now to get what could be the most urgent, and most lucrative research, my team has ever r About Phreesia Stock (NYSE:PHR)Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.Read More PHR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PHR Stock News HeadlinesMarch 19, 2024 | americanbankingnews.comPhreesia (NYSE:PHR) Earns Market Outperform Rating from JMP SecuritiesMarch 19, 2024 | americanbankingnews.comPhreesia (NYSE:PHR) Price Target Increased to $31.00 by Analysts at Robert W. BairdMarch 19, 2024 | Weiss Ratings (Ad)The ONE AI sSock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …March 19, 2024 | americanbankingnews.comPhreesia (NYSE:PHR) Price Target Raised to $37.00 at Canaccord Genuity GroupMarch 19, 2024 | americanbankingnews.comPhreesia (NYSE:PHR) Price Target Increased to $23.00 by Analysts at Royal Bank of CanadaMarch 19, 2024 | americanbankingnews.comPhreesia's (PHR) "Buy" Rating Reaffirmed at Needham & Company LLCMarch 18, 2024 | msn.comStock Market News for Mar 18, 2024March 17, 2024 | finance.yahoo.comPhreesia, Inc. (NYSE:PHR) Q4 2024 Earnings Call TranscriptMarch 19, 2024 | Crypto 101 Media (Ad)Like Tiny Crypto Retirement FundsThe crypto bull market is about to blast off. Bitcoin and Ethereum are surging. But so are tiny altcoins that could be so profitable… They're like tiny crypto retirement funds. March 16, 2024 | seekingalpha.comPhreesia, Inc. (PHR) Q4 2024 Earnings Call TranscriptMarch 16, 2024 | americanbankingnews.comPhreesia (NYSE:PHR) Shares Gap Up on Earnings BeatMarch 15, 2024 | finance.yahoo.comPHR Dec 2024 20.000 putMarch 15, 2024 | finance.yahoo.comPHR Jun 2024 17.500 callMarch 15, 2024 | msn.comParenthood Motivates Workers To Be More Productive, New Report ShowsMarch 15, 2024 | markets.businessinsider.comRBC Capital Reaffirms Their Hold Rating on Phreesia (PHR)March 15, 2024 | ca.finance.yahoo.comPHR Jul 2024 30.000 callMarch 15, 2024 | finance.yahoo.comQ4 2024 Phreesia Inc Earnings CallMarch 14, 2024 | investorplace.comPHR Stock Earnings: Phreesia Misses EPS, Beats Revenue for Q4 2024March 14, 2024 | benzinga.comRecap: Phreesia Q4 EarningsMarch 14, 2024 | sfgate.comPhreesia: Fiscal Q4 Earnings SnapshotMarch 14, 2024 | businesswire.comPhreesia Announces Fourth Quarter Fiscal 2024 ResultsMarch 14, 2024 | finance.yahoo.comPHR Jul 2024 17.500 callMarch 14, 2024 | finance.yahoo.comPHR Jul 2024 25.000 putMarch 13, 2024 | msn.comPhreesia Q4 2024 Earnings PreviewMarch 13, 2024 | markets.businessinsider.comHere's what Wall Street expects from Phreesia's earningsMarch 12, 2024 | finance.yahoo.comTruveris Announces C-Suite Appointments & Leadership PromotionsMarch 12, 2024 | markets.businessinsider.comPhreesia (PHR) Receives a Buy from JMP SecuritiesSee More Headlines Receive PHR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Phreesia and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2024Today3/18/2024Next Earnings (Estimated)5/29/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Business services, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:PHR CUSIPN/A CIK1412408 Webwww.phreesia.com Phone(888) 654-7473Fax646-607-1776Employees1,546Year FoundedN/APrice Target and Rating Average Stock Price Target$32.71 High Stock Price Target$40.00 Low Stock Price Target$23.00 Potential Upside/Downside+47.3%Consensus RatingModerate Buy Rating Score (0-4)2.93 Research Coverage15 Analysts Profitability EPS (Most Recent Fiscal Year)($2.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-176,150,000.00 Net Margins-38.42% Pretax Margin-42.35% Return on Equity-52.97% Return on Assets-38.42% Debt Debt-to-Equity Ratio0.03 Current Ratio2.02 Quick Ratio2.02 Sales & Book Value Annual Sales$356.30 million Price / Sales3.58 Cash FlowN/A Price / Cash FlowN/A Book Value$5.46 per share Price / Book4.20Miscellaneous Outstanding Shares55,630,000Free Float52,408,000Market Cap$1.28 billion OptionableOptionable Beta0.93 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Chaim Indig (Age 45)Co-Founder, CEO & Director Comp: $515kMr. Evan Roberts (Age 45)Co-Founder & COO Comp: $400kMr. David Linetsky (Age 44)Senior Vice President of Life Sciences Comp: $551.64kMr. Balaji Gandhi (Age 50)Chief Financial Officer Ms. Janet M. Gunzburg (Age 58)VP, Principal Accounting Officer & Controller Mr. Jack CallahanChief Technology OfficerMs. Allison C. Hoffman (Age 53)General Counsel & Secretary Comp: $418.96kMs. Maureen McKinneyVice President of Corporate CommunicationsMs. Kharen HauckVice President of MarketingMs. Amy Beth VanDuyn (Age 51)Senior Vice President of Human Resources More ExecutivesKey CompetitorsMultiPlanNYSE:MPLNOmnicellNASDAQ:OMCLDay One BiopharmaceuticalsNASDAQ:DAWNDeciphera PharmaceuticalsNASDAQ:DCPHMirum PharmaceuticalsNASDAQ:MIRMView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 194,035 shares on 3/11/2024Ownership: 8.320%American International Group Inc.Bought 591 shares on 2/28/2024Ownership: 0.047%Price T Rowe Associates Inc. MDBought 26,868 shares on 2/16/2024Ownership: 0.134%Prelude Capital Management LLCBought 3,561 shares on 2/15/2024Ownership: 0.060%Mercer Global Advisors Inc. ADVSold 3,442 shares on 2/15/2024Ownership: 0.016%View All Insider TransactionsView All Institutional Transactions PHR Stock Analysis - Frequently Asked Questions Should I buy or sell Phreesia stock right now? 15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Phreesia in the last year. There are currently 2 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PHR shares. View PHR analyst ratings or view top-rated stocks. What is Phreesia's stock price target for 2024? 15 analysts have issued twelve-month price targets for Phreesia's stock. Their PHR share price targets range from $23.00 to $40.00. On average, they expect the company's stock price to reach $32.71 in the next year. This suggests a possible upside of 42.7% from the stock's current price. View analysts price targets for PHR or view top-rated stocks among Wall Street analysts. How have PHR shares performed in 2024? Phreesia's stock was trading at $23.15 on January 1st, 2024. Since then, PHR shares have decreased by 1.0% and is now trading at $22.93. View the best growth stocks for 2024 here. When is Phreesia's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 29th 2024. View our PHR earnings forecast. How were Phreesia's earnings last quarter? Phreesia, Inc. (NYSE:PHR) announced its quarterly earnings data on Thursday, March, 14th. The company reported ($0.56) earnings per share for the quarter, topping analysts' consensus estimates of ($0.58) by $0.02. The firm earned $95 million during the quarter, compared to the consensus estimate of $93.52 million. Phreesia had a negative trailing twelve-month return on equity of 52.97% and a negative net margin of 38.42%. The company's quarterly revenue was up 24.0% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.72) EPS. What ETFs hold Phreesia's stock? ETFs with the largest weight of Phreesia (NYSE:PHR) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), Fidelity Disruptive Medicine ETF (FMED) and iShares U.S. Healthcare Providers ETF (IHF) and What guidance has Phreesia issued on next quarter's earnings? Phreesia updated its FY 2025 earnings guidance on Thursday, March, 14th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $424.0 million-$434.0 million, compared to the consensus revenue estimate of $428.1 million. What is Chaim Indig's approval rating as Phreesia's CEO? 172 employees have rated Phreesia Chief Executive Officer Chaim Indig on Glassdoor.com. Chaim Indig has an approval rating of 73% among the company's employees. What other stocks do shareholders of Phreesia own? Based on aggregate information from My MarketBeat watchlists, some companies that other Phreesia investors own include Fastly (FSLY), Zscaler (ZS), Okta (OKTA), DocuSign (DOCU), HealthEquity (HQY), Block (SQ), Appian (APPN), Walt Disney (DIS), Globant (GLOB) and Invitae (NVTA). When did Phreesia IPO? (PHR) raised $127 million in an IPO on Thursday, July 18th 2019. The company issued 7,800,000 shares at $15.00-$17.62 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray acted as the underwriters for the IPO. Who are Phreesia's major shareholders? Phreesia's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.32%), Vanguard Group Inc. (8.32%), Brown Advisory Inc. (7.10%), Franklin Resources Inc. (2.67%), GW&K Investment Management LLC (2.17%) and Ophir Asset Management Pty Ltd (1.98%). Insiders that own company stock include Allison C Hoffman, Allison C Hoffman, Amy Beth Vanduyn, Balaji Gandhi, Chaim Indig, David Linetsky, Edward L Cahill, Evan Roberts, Gillian Munson, Janet Gunzburg, Mark Douglas Smith, Michael J Davidoff, Michael Weintraub and Randy Rasmussen. View institutional ownership trends. How do I buy shares of Phreesia? Shares of PHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:PHR) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phreesia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.